RPRX Royalty Pharma plc
$58.61
Royalty Pharma plc (RPRX) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Insider signal
In line
Selling ran in line with RPRX's own trailing one-year pace, with 100% of sale value under a prearranged plan.
Cluster activity
0 buyers in the last 30 days
0 buyers in the last 90 days
3 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
5
70 transactions
Purchases
$0
0 shares
Sales
$86.5M
1,937,588 shares
Net activity
-$86.5M
purchases less sales
How much of that selling was preplanned? 100% planned / 0% discretionary
10b5-1 plan sales
$86.5M
70 transactions · 1,937,588 shares
Discretionary sales
$0
0 transactions · 0 shares
Largest single sale: $6.4M.
Where they traded
Buy
Sell
Dot area is proportional to transaction value.
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Hite Christopher | EVP & Chairman, Partnering | Sell 10b5-1 | 100,000 | $59.97 | $6.0M | 370,401 −21.3% of holding | |
| Coyne Terrance P. 2 fills | EVP & CFO | Sell 10b5-1 | 11,002 | $58.68 | $645.6K | 1,772 −86.1% of holding | |
| Urist Marshall | EVP, Research & Investments | Sell 10b5-1 | 9,099 | $55.88 | $508.5K | None left | |
| Hite Christopher 4 fills | EVP & Chairman, Partnering | Sell 10b5-1 | 130,000 | $56.50 | $7.3M | 461,953 −22% of holding | |
| Urist Marshall | EVP, Research & Investments | Sell 10b5-1 | 9,098 | $55.18 | $502.1K | 9,099 −50% of holding | |
| Hite Christopher 2 fills | EVP & Chairman, Partnering | Sell 10b5-1 | 150,000 | $54.40 | $8.2M | 676,991 −18.1% of holding | |
| Coyne Terrance P. | EVP & CFO | Sell 10b5-1 | 64,399 | $53.98 | $3.5M | None left | |
| Urist Marshall | EVP, Research & Investments | Sell 10b5-1 | 13,684 | $52.75 | $721.8K | 18,197 −42.9% of holding | |
| Urist Marshall | EVP, Research & Investments | Sell 10b5-1 | 13,684 | $53.06 | $726.1K | 31,881 −30% of holding | |
| Norden Gregory | Director | Sell 10b5-1 | 3,045 | $53.00 | $161.4K | 191,803 −1.6% of holding | |
| Coyne Terrance P. 2 fills | EVP & CFO | Sell 10b5-1 | 34,791 | $49.78 | $1.7M | 40,136 −46.4% of holding | |
| Coyne Terrance P. 2 fills | EVP & CFO | Sell 10b5-1 | 34,791 | $48.33 | $1.7M | 42,011 −45.3% of holding | |
| Coyne Terrance P. 2 fills | EVP & CFO | Sell 10b5-1 | 34,791 | $45.53 | $1.6M | 65,832 −34.6% of holding | |
| Coyne Terrance P. 4 fills | EVP & CFO | Sell 10b5-1 | 34,791 | $46.78 | $1.6M | 109,177 −24.2% of holding | |
| Coyne Terrance P. 2 fills | EVP & CFO | Sell 10b5-1 | 34,791 | $45.32 | $1.6M | 131,664 −20.9% of holding | |
| Coyne Terrance P. 2 fills | EVP & CFO | Sell 10b5-1 | 20,163 | $43.29 | $872.9K | 164,580 −10.9% of holding | |
| Coyne Terrance P. 2 fills | EVP & CFO | Sell 10b5-1 | 114,954 | $42.84 | $4.9M | 183,656 −38.5% of holding | |
| Coyne Terrance P. 2 fills | EVP & CFO | Sell 10b5-1 | 108,424 | $42.08 | $4.6M | 292,415 −27% of holding | |
| Urist Marshall | EVP, Research & Investments | Sell 10b5-1 | 20,000 | $41.09 | $821.8K | None left | |
| Urist Marshall | EVP, Research & Investments | Sell 10b5-1 | 20,000 | $40.26 | $805.1K | 20,000 −50% of holding | |
| Coyne Terrance P. 2 fills | EVP & CFO | Sell 10b5-1 | 69,582 | $39.35 | $2.7M | 394,996 −15% of holding | |
| Urist Marshall | EVP, Research & Investments | Sell 10b5-1 | 20,000 | $39.52 | $790.3K | 40,000 −33.3% of holding | |
| Urist Marshall | EVP, Research & Investments | Sell 10b5-1 | 20,000 | $40.78 | $815.6K | 60,000 −25% of holding | |
| Coyne Terrance P. 2 fills | EVP & CFO | Sell 10b5-1 | 69,582 | $38.42 | $2.7M | 460,828 −13.1% of holding | |
| Urist Marshall | EVP, Research & Investments | Sell 10b5-1 | 20,000 | $38.48 | $769.7K | 80,000 −20% of holding | |
| Urist Marshall | EVP, Research & Investments | Sell 10b5-1 | 20,000 | $39.32 | $786.4K | 100,000 −16.7% of holding | |
| Urist Marshall | EVP, Research & Investments | Sell 10b5-1 | 20,000 | $38.38 | $767.6K | 120,000 −14.3% of holding | |
| Lloyd George W. | EVP, Investments & CLO | Sell 10b5-1 | 30,654 | $38.50 | $1.2M | None left | |
| Lloyd George W. | EVP, Investments & CLO | Sell 10b5-1 | 79,346 | $38.57 | $3.1M | 30,654 −72.1% of holding | |
| Urist Marshall | EVP, Research & Investments | Sell 10b5-1 | 20,000 | $38.32 | $766.4K | 140,000 −12.5% of holding | |
| Coyne Terrance P. 2 fills | EVP & CFO | Sell 10b5-1 | 69,582 | $38.36 | $2.7M | 526,660 −11.7% of holding | |
| Urist Marshall 2 fills | EVP, Research & Investments | Sell 10b5-1 | 41,576 | $39.15 | $1.6M | 160,000 −20.6% of holding | |
| Lloyd George W. | EVP, Investments & CLO | Sell 10b5-1 | 110,000 | $39.77 | $4.4M | 110,000 −50% of holding | |
| Coyne Terrance P. 2 fills | EVP & CFO | Sell 10b5-1 | 69,582 | $39.87 | $2.8M | 592,492 −10.5% of holding | |
| Urist Marshall 2 fills | EVP, Research & Investments | Sell 10b5-1 | 41,575 | $39.92 | $1.7M | 183,334 −18.5% of holding | |
| Coyne Terrance P. 4 fills | EVP & CFO | Sell 10b5-1 | 69,582 | $38.55 | $2.7M | 669,010 −9.4% of holding | |
| Lloyd George W. 8 fills | EVP, Investments & CLO | Sell 10b5-1 | 135,426 | $38.34 | $5.2M | 10,712 −92.7% of holding | |
| Coyne Terrance P. 2 fills | EVP & CFO | Sell 10b5-1 | 69,594 | $39.30 | $2.7M | 724,156 −8.8% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.